Induced Pluripotent Stem Cells Market Overview
Induced Pluripotent Stem Cells Market was valued at US$ 2 Billion in 2024 and is projected to grow at a CAGR of 6.80% to reach US$ 3.9 Billion by 2034.
Induced Pluripotent Stem Cells (iPSC) are derived from blood and skin cells which are reprogrammed back into embryonic-like pluripotent state by enabling development of unlimited source of any human cell required for various therapeutic purpose.
Growing prevalence of cancer diseases and research activities in Induced Pluripotent Stem Cells has become major factor in market growth. Growing number of major players and research organizations to develop therapeutic potency of stem cell-based products has further powered the market growth. Wide applications in regenerative medicine, drug development, tissue engineering, toxicity testing, cell therapy and others is anticipated to increase the demand for Induced Pluripotent Stem Cells market growth over the forecast period.
Induced Pluripotent Stem Cells Market Dynamics
Growing prevalence of diseases and demand for therapies has become a leading factor in market growth. As induced potential stem cells comes from patients own cells it offers great therapeutic potential which in turn boost the demand for market growth. Cancer are chronic diseases are growing rapidly due to unhealthy lifestyle and poor nutrition food. Use of induced pluripotent stem cell in therapies has driven the demand for market growth.
For instance, in 2022, according to PubMed Central, the study showed that induced pluripotent stem cells offers unlimited supply for therapies such as cell therapy due to its ability to be genetically engineered and its unique self-renewal properties.
For instance in April 2023, Mission Ax-2 has set to launch stem cells to space. This upcoming mission will be producing induced pluripotent stem cells in microgravity by Astronauts with large batches of iPSCs for utilizing them in application for new drug development and therapies to improve function of heart.
Restrains:
However, expensive treatments and lack of awareness regarding stem cell therapies has hampered the demand for Induced Pluripotent Stem Cells market growth.
Induced Pluripotent Stem Cells Market Segmentation
Induced Pluripotent Stem Cells Market is segmented based on Derived Cell Type, Application, End-Users and Region.
Derived Cell Type Insight
On the basis of Derived Cell Type, Induced Pluripotent Stem Cells Market is segmented into Neurons, Fibroblasts, Hepatocytes, Keratinocytes and Others.
Application Insights
On the basis of Application, Induced Pluripotent Stem Cells Market is segmented into Regenerative Medicine, Drug Development, Tissue Engineering, Toxicity Testing, Cell Therapy and Others. Drug Development application segment is expected to dominate the target market growth owing to growing prevalence of chronic diseases like cancer, heart disease, diabetes and others and use of induced pluripotent stem cells in understanding the disease & disease modelling to develop innovative drug and treatment plans has boost the segment growth.
End-Users Insights
On the basis of End-Users, Induced Pluripotent Stem Cells Market is segmented into Research & Academic Institutes, Hospital & Clinics, Pharmaceutical Companies and Others. Research & Academic Institutes end-user segment is expected to dominate the market growth due to growing research & development activities in induced pluripotent stem cells to estimate safe and efficient iPSCs treatment.
Regional Insights:
On region the Induced Pluripotent Stem Cells Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period. Moreover, rising prevalence of chronic disease, unhealthy diet, sedentary lifestyle, high disposable income, ongoing clinical trials, government funding and presence of well-advanced research institutes is anticipated to increase demand for Induced Pluripotent Stem Cells in the region.
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Derived Cell Type - Neurons, Fibroblasts, Hepatocytes, Keratinocytes and Others. By Application - Regenerative Medicine, Drug Development, Tissue Engineering, Toxicity Testing, Cell Therapy and Others By End-Users - Research & Academic Institutes, Hospital & Clinics, Pharmaceutical Companies and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Induced Pluripotent Stem Cells Market report based on Derived Cell Type, Application, End-Users and Region.
Induced Pluripotent Stem Cells Market, By Derived Cell Type:
- Neurons
- Fibroblasts
- Hepatocytes
- Keratinocytes
- Others
Induced Pluripotent Stem Cells Market, By Application:
- Regenerative Medicine
- Drug Development
- Tissue Engineering
- Toxicity Testing
- Cell Therapy
- Others
Induced Pluripotent Stem Cells Market, By End-Users:
- Research & Academic Institutes
- Hospital & Clinics
- Pharmaceutical Companies
- Others
Induced Pluripotent Stem Cells Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- U.S.
- Canada
- Middle East & Africa
Induced Pluripotent Stem Cells Market Key Players
The key players operating the Induced Pluripotent Stem Cells Market includes, Lonza, Evotec SE, Thermo Fisher Scientific Inc., Axol Bioscience Ltd., Merck KGaA, Fate Therapeutics, Hitachi Ltd., Cynata Therapeutics Limited, Applied StemCells Inc., REPROCELLS Inc., and others.
Induced Pluripotent Stem Cells Market Key Issues Addressed
Recent Development:
- In June 2023, Applied StemCell Inc., partnered with CIRM (California Institute for Regenerative Medicine) to offer clinical-grade induced pluripotent stem cells with MCB (master cell bank) and WCB (working cell bank) and to access its proprietary gene editing technologies for accelerating the development of advanced regenerative therapies.
- In October 2022, Synthego launched high throughput genome engineering for induced pluripotent stem cells. The new launched tool will expand the Synthego’s efficiency of induced pluripotent cells at an industrial scale.
- In November 2020, FUJIFILM Cellular Dynamics and Lonza Walkersville, Inc., signed an agreement to expand availability of induced pluripotent stem cell technology to enable the drug developers for leveraging both companies to use their patent technology for generating iPSCs (induced pluripotent stem cells).
Induced Pluripotent Stem Cells Market Company Profile
- Lonza*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Evotec SE
- Thermo Fisher Scientific Inc.
- Axol Bioscience Ltd.
- Merck KGaA
- Fate Therapeutics
- Hitachi Ltd.
- Cynata Therapeutics Limited
- Applied StemCells Inc.
- REPROCELLS Inc.
“*” marked represents similar segmentation in other categories in the respective section
Induced Pluripotent Stem Cells Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Derived Cell Type
- Market Snippet, By Application
- Market Snippet, By End-Users
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Induced Pluripotent Stem Cells Market, By Derived Cell Type
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Neurons
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Fibroblasts
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Hepatocytes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Keratinocytes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Induced Pluripotent Stem Cells Market, By Application, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Regenerative Medicine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Drug Development
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Tissue Engineering
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Toxicity Testing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Cell Therapy
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Induced Pluripotent Stem Cells Market, By End-Users, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Research & Academic Institutes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Hospital & Clinics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Pharmaceutical Companies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Induced Pluripotent Stem Cells Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Derived Cell Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Derived Cell Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Derived Cell Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Overview
-
- Latin America
- Market Size and Forecast (US$ Bn), By Derived Cell Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Latin America
-
-
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Derived Cell Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
-
-
-
-
- GCC
- Israel
- South Africa
- Rest of Middle East
-
-
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Lonza
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Evotec SE
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Axol Bioscience Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Fate Therapeutics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hitachi Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cynata Therapeutics Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Applied StemCells Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- REPROCELLS Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Induced Pluripotent Stem Cells Market is segmented into Derived Cell Type, Application, End-Users and Region.
Induced Pluripotent Stem Cells Market is driven by factors like growing prevalence of diseases and demand for therapies.
By region, the Induced Pluripotent Stem Cells market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating the Induced Pluripotent Stem Cells Market includes, Lonza, Evotec SE, Thermo Fisher Scientific Inc., Axol Bioscience Ltd., Merck KGaA, Fate Therapeutics, Hitachi Ltd., Cynata Therapeutics Limited, Applied StemCells Inc., REPROCELLS Inc., and others.
Induced Pluripotent Stem Cells Market was valued at US$ 2 Billion in 2024 and is projected to grow at a CAGR of 6.80% to reach US$ 3.9 Billion by 2034.